DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
FDA Requires Randomized Data to Support PI3K Inhibitor Approvals
The Oncologic Drugs Advisory Committee (ODAC) convened a meeting on April 21, 2022, to ...
Designing Patient-Centric Decentralized Clinical Trials
“Best Practices For Designing Patient-Centric Decentralized Clinical Trials” by Jessica ...
Starting Social Media as a CMO: Strategic Considerations to Know
Not all Chief Medical Officers (CMOs) are public facing with marketing experience, and ...
Why It’s Never Too Early for Small Biotechs to Harness Clinical Data
Halloran’s webinar in partnership with CSL Behring on “Moving from Excel to Complete ...
How Small Biotechs Can Prepare For & Navigate CRO M&As
“How Small Biotechs Can Prepare For & Navigate CRO M&As” was originally published ...
Why Hybrid Trials May Be the Best Choice for Patient Centricity
“Why Hybrid Trials May Be the Best Choice for Patient Centricity” was originally ...
Clinical Trial Sponsor Oversight For Mitigating Misconduct & Fraud
“Essential Elements Of Clinical Trial Sponsor Oversight For Mitigating Scientific ...
The Criticality of CMO Selection for Small Biopharma Companies
For pre-clinical or early-stage biopharma companies, selecting the right Contract ...
New FDA Guidance for Drug and Biological Product Submissions
On December 13, 2016, the 21st Century Cures Act (Cures Act) was signed into law, to help ...
Lessons Learned from Designing a Modern R&D Technology Architecture
Two industry leaders and veterans, Raj Indupuri, eClinical Solutions Co-Founder and CEO ...